2021 Dallemagne Lectureship in Surgical Innovation Enduring Material Non-CME
Esophageal and foregut disease is a rapidly-developing medical area marked by significant advances in diagnosis, and treatment of new diseases. Dr. Alejandro Nieponice (MD, PhD) is currently the Chief of The Esophageal Unit at Hospital Universitario Fundación Favaloro in Buenos Aires, Argentina. He is also a faculty member of the McGowan Institute for Regenerative Medicine and an Adjunct Research Assistant Professor of the Department of Surgery at the University of Pittsburgh. Dr. Nieponice has pioneered the treatment of esophageal reflux with electrical stimulation of the lower esophageal sphincter becoming the first surgeon worldwide to treat successfully a patient with reflux after a sleeve gastrectomy. He has also developed a program of interventional endoscopy for the treatment of early esophageal cancer and achalasia.
Esophageal & Foregut surgeons & Fellows
- Discuss ECM for tissue regeneration, electrical stimulation techniques as treatment for the lower esophageal sphincter
- Review other emerging treatments and technologies.
|2021 Dallemagne Lecture Agenda.docx||12.95 KB|
|N_ Nieponice Disclosure form.pdf||80.59 KB|
|N-Jobe 2021 Dallemagne Disclosure form.pdf||80.61 KB|
Blair Jobe, MD
Alejandro Nieponice, MD, PhD
No conflicts identified with Course Director or Invited Speaker
Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Allegheny General Hospital designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.